Recently approved antibacterials for methicillin-resistant Staphylococcus aureus (MRSA) and other Gram-positive pathogens: the shock of the new.
Identifieur interne : 000481 ( Main/Exploration ); précédent : 000480; suivant : 000482Recently approved antibacterials for methicillin-resistant Staphylococcus aureus (MRSA) and other Gram-positive pathogens: the shock of the new.
Auteurs : Michael Z. David [États-Unis] ; Matthew Dryden [Royaume-Uni] ; Thomas Gottlieb [Australie] ; Pierre Tattevin [France] ; Ian M. Gould [Royaume-Uni]Source :
- International journal of antimicrobial agents [ 1872-7913 ] ; 2017.
Abstract
A number of novel antimicrobial drugs with activity against Gram-positive bacterial pathogens have been licensed in the past 4 years. These drugs have the potential to enrich the group of intravenous drugs already available that are in common use against methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant enterococci and other antibiotic-resistant Gram-positive pathogens. The advantages and disadvantages of these drugs are not yet fully appreciated. Here we review the five most promising newly approved compounds, namely ceftaroline, ceftobiprole, oritavancin, dalbavancin and tedizolid. The advantages of their dosing regimens, mechanisms of action and adverse effect profiles as well as evidence for their clinical usefulness and the unique characteristics that distinguish them from one another and from older drugs are reviewed.
DOI: 10.1016/j.ijantimicag.2017.05.006
PubMed: 28666751
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 000539
- to stream PubMed, to step Curation: 000537
- to stream PubMed, to step Checkpoint: 000537
- to stream Ncbi, to step Merge: 004A59
- to stream Ncbi, to step Curation: 004A59
- to stream Ncbi, to step Checkpoint: 004A59
- to stream Main, to step Merge: 000476
- to stream Main, to step Curation: 000481
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Recently approved antibacterials for methicillin-resistant Staphylococcus aureus (MRSA) and other Gram-positive pathogens: the shock of the new.</title><author><name sortKey="David, Michael Z" sort="David, Michael Z" uniqKey="David M" first="Michael Z" last="David">Michael Z. David</name><affiliation wicri:level="2"><nlm:affiliation>Department of Medicine, University of Chicago, 5841 S. Maryland Ave., MC6054, Chicago, IL 60637, USA. Electronic address: mdavid@medicine.bsd.uchicago.edu.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Medicine, University of Chicago, 5841 S. Maryland Ave., MC6054, Chicago, IL 60637</wicri:regionArea><placeName><region type="state">Illinois</region></placeName></affiliation></author><author><name sortKey="Dryden, Matthew" sort="Dryden, Matthew" uniqKey="Dryden M" first="Matthew" last="Dryden">Matthew Dryden</name><affiliation wicri:level="1"><nlm:affiliation>Department of Microbiology and Communicable Diseases, Royal Hampshire County Hospital, Winchester, Hampshire, UK.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Department of Microbiology and Communicable Diseases, Royal Hampshire County Hospital, Winchester, Hampshire</wicri:regionArea><wicri:noRegion>Hampshire</wicri:noRegion></affiliation></author><author><name sortKey="Gottlieb, Thomas" sort="Gottlieb, Thomas" uniqKey="Gottlieb T" first="Thomas" last="Gottlieb">Thomas Gottlieb</name><affiliation wicri:level="1"><nlm:affiliation>Department of Microbiology and Infectious Diseases, Concord Repatriation General Hospital, Sydney, NSW, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>Department of Microbiology and Infectious Diseases, Concord Repatriation General Hospital, Sydney, NSW</wicri:regionArea><wicri:noRegion>NSW</wicri:noRegion></affiliation></author><author><name sortKey="Tattevin, Pierre" sort="Tattevin, Pierre" uniqKey="Tattevin P" first="Pierre" last="Tattevin">Pierre Tattevin</name><affiliation wicri:level="3"><nlm:affiliation>Infectious Diseases and Intensive Care Unit, Pontchaillou University Hospital, Rennes, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Infectious Diseases and Intensive Care Unit, Pontchaillou University Hospital, Rennes</wicri:regionArea><placeName><region type="region">Région Bretagne</region><region type="old region">Région Bretagne</region><settlement type="city">Rennes</settlement></placeName></affiliation></author><author><name sortKey="Gould, Ian M" sort="Gould, Ian M" uniqKey="Gould I" first="Ian M" last="Gould">Ian M. Gould</name><affiliation wicri:level="1"><nlm:affiliation>Medical Microbiology Department, Aberdeen Royal Infirmary, Aberdeen, UK.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Medical Microbiology Department, Aberdeen Royal Infirmary, Aberdeen</wicri:regionArea><wicri:noRegion>Aberdeen</wicri:noRegion></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2017">2017</date><idno type="RBID">pubmed:28666751</idno><idno type="pmid">28666751</idno><idno type="doi">10.1016/j.ijantimicag.2017.05.006</idno><idno type="wicri:Area/PubMed/Corpus">000539</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000539</idno><idno type="wicri:Area/PubMed/Curation">000537</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000537</idno><idno type="wicri:Area/PubMed/Checkpoint">000537</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000537</idno><idno type="wicri:Area/Ncbi/Merge">004A59</idno><idno type="wicri:Area/Ncbi/Curation">004A59</idno><idno type="wicri:Area/Ncbi/Checkpoint">004A59</idno><idno type="wicri:Area/Main/Merge">000476</idno><idno type="wicri:Area/Main/Curation">000481</idno><idno type="wicri:Area/Main/Exploration">000481</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Recently approved antibacterials for methicillin-resistant Staphylococcus aureus (MRSA) and other Gram-positive pathogens: the shock of the new.</title><author><name sortKey="David, Michael Z" sort="David, Michael Z" uniqKey="David M" first="Michael Z" last="David">Michael Z. David</name><affiliation wicri:level="2"><nlm:affiliation>Department of Medicine, University of Chicago, 5841 S. Maryland Ave., MC6054, Chicago, IL 60637, USA. Electronic address: mdavid@medicine.bsd.uchicago.edu.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Medicine, University of Chicago, 5841 S. Maryland Ave., MC6054, Chicago, IL 60637</wicri:regionArea><placeName><region type="state">Illinois</region></placeName></affiliation></author><author><name sortKey="Dryden, Matthew" sort="Dryden, Matthew" uniqKey="Dryden M" first="Matthew" last="Dryden">Matthew Dryden</name><affiliation wicri:level="1"><nlm:affiliation>Department of Microbiology and Communicable Diseases, Royal Hampshire County Hospital, Winchester, Hampshire, UK.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Department of Microbiology and Communicable Diseases, Royal Hampshire County Hospital, Winchester, Hampshire</wicri:regionArea><wicri:noRegion>Hampshire</wicri:noRegion></affiliation></author><author><name sortKey="Gottlieb, Thomas" sort="Gottlieb, Thomas" uniqKey="Gottlieb T" first="Thomas" last="Gottlieb">Thomas Gottlieb</name><affiliation wicri:level="1"><nlm:affiliation>Department of Microbiology and Infectious Diseases, Concord Repatriation General Hospital, Sydney, NSW, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>Department of Microbiology and Infectious Diseases, Concord Repatriation General Hospital, Sydney, NSW</wicri:regionArea><wicri:noRegion>NSW</wicri:noRegion></affiliation></author><author><name sortKey="Tattevin, Pierre" sort="Tattevin, Pierre" uniqKey="Tattevin P" first="Pierre" last="Tattevin">Pierre Tattevin</name><affiliation wicri:level="3"><nlm:affiliation>Infectious Diseases and Intensive Care Unit, Pontchaillou University Hospital, Rennes, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Infectious Diseases and Intensive Care Unit, Pontchaillou University Hospital, Rennes</wicri:regionArea><placeName><region type="region">Région Bretagne</region><region type="old region">Région Bretagne</region><settlement type="city">Rennes</settlement></placeName></affiliation></author><author><name sortKey="Gould, Ian M" sort="Gould, Ian M" uniqKey="Gould I" first="Ian M" last="Gould">Ian M. Gould</name><affiliation wicri:level="1"><nlm:affiliation>Medical Microbiology Department, Aberdeen Royal Infirmary, Aberdeen, UK.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Medical Microbiology Department, Aberdeen Royal Infirmary, Aberdeen</wicri:regionArea><wicri:noRegion>Aberdeen</wicri:noRegion></affiliation></author></analytic><series><title level="j">International journal of antimicrobial agents</title><idno type="eISSN">1872-7913</idno><imprint><date when="2017" type="published">2017</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">A number of novel antimicrobial drugs with activity against Gram-positive bacterial pathogens have been licensed in the past 4 years. These drugs have the potential to enrich the group of intravenous drugs already available that are in common use against methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant enterococci and other antibiotic-resistant Gram-positive pathogens. The advantages and disadvantages of these drugs are not yet fully appreciated. Here we review the five most promising newly approved compounds, namely ceftaroline, ceftobiprole, oritavancin, dalbavancin and tedizolid. The advantages of their dosing regimens, mechanisms of action and adverse effect profiles as well as evidence for their clinical usefulness and the unique characteristics that distinguish them from one another and from older drugs are reviewed.</div></front></TEI><affiliations><list><country><li>Australie</li><li>France</li><li>Royaume-Uni</li><li>États-Unis</li></country><region><li>Illinois</li><li>Région Bretagne</li></region><settlement><li>Rennes</li></settlement></list><tree><country name="États-Unis"><region name="Illinois"><name sortKey="David, Michael Z" sort="David, Michael Z" uniqKey="David M" first="Michael Z" last="David">Michael Z. David</name></region></country><country name="Royaume-Uni"><noRegion><name sortKey="Dryden, Matthew" sort="Dryden, Matthew" uniqKey="Dryden M" first="Matthew" last="Dryden">Matthew Dryden</name></noRegion><name sortKey="Gould, Ian M" sort="Gould, Ian M" uniqKey="Gould I" first="Ian M" last="Gould">Ian M. Gould</name></country><country name="Australie"><noRegion><name sortKey="Gottlieb, Thomas" sort="Gottlieb, Thomas" uniqKey="Gottlieb T" first="Thomas" last="Gottlieb">Thomas Gottlieb</name></noRegion></country><country name="France"><region name="Région Bretagne"><name sortKey="Tattevin, Pierre" sort="Tattevin, Pierre" uniqKey="Tattevin P" first="Pierre" last="Tattevin">Pierre Tattevin</name></region></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000481 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000481 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Asie
|area= AustralieFrV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:28666751
|texte= Recently approved antibacterials for methicillin-resistant Staphylococcus aureus (MRSA) and other Gram-positive pathogens: the shock of the new.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:28666751" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a AustralieFrV1
| This area was generated with Dilib version V0.6.33. |  |